RECURSION PHARMACEUTICALS, INC. — Investor Relations & Filings

Recursion Pharmaceuticals is a clinical-stage company that applies artificial intelligence and machine learning to drug discovery. Its central platform, the Recursion Operating System (OS), integrates automated wet-lab biology with advanced computational tools to industrialize the process. By generating vast, proprietary biological and chemical datasets from millions of weekly cellular experiments, the company trains its models to decode biology, identify novel drug targets, and design potential medicines. Recursion's pipeline focuses on developing treatments for conditions with high unmet need, such as rare diseases and aggressive cancers. The company's approach aims to significantly accelerate the drug discovery timeline, improve efficiency, and reduce the high failure rates common in traditional pharmaceutical development.